Rafina Innovations Inc. (VICA)
OTCMKTS · Delayed Price · Currency is USD
0.0007
+0.0004 (133.33%)
At close: Dec 16, 2025
Rafina Innovations Market Cap
Rafina Innovations has a market cap or net worth of $97.29 thousand as of December 24, 2025. Its market cap has decreased by -92.09% in one year.
Market Cap
97.29K
Enterprise Value
n/a
Revenue
335.15K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since October 23, 2013, Rafina Innovations's market cap has decreased from 2.49M to 97.29K, a decrease of -96.09%. That is a compound annual growth rate of -23.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 16, 2025 | 97.29K | 69,889.21% |
| Dec 28, 2023 | 139.00 | -99.93% |
| Dec 30, 2022 | 208.47K | -86.36% |
| Dec 31, 2021 | 1.53M | -22.00% |
| Dec 31, 2020 | 1.96M | 41.76% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 24, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 764.81M |
| Glass House Brands | 730.42M |
| Elite Pharmaceuticals | 515.58M |
| American Oncology Network | 394.40M |
| Northwest Biotherapeutics | 390.29M |
| CytoDyn | 359.24M |
| Silence Therapeutics | 296.16M |
| Nika Pharmaceuticals | 291.10M |